BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19168426)

  • 1. Conformational analysis (geometry optimization) of nucleosidic antitumor antibiotic showdomycin by Arguslab 4 software.
    Naz A; Bano K; Bano F; Ghafoor NA; Akhtar N
    Pak J Pharm Sci; 2009 Jan; 22(1):78-82. PubMed ID: 19168426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational study on the geometry optimization and excited - state properties of riboflavin by ArgusLab 4.0.1.
    Hafeez A; Naz A; Naeem S; Bano K; Akhtar N
    Pak J Pharm Sci; 2013 May; 26(3):487-93. PubMed ID: 23625421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational analysis and geometry optimization of buspirone-A 5-HT1A receptor agonist.
    Ikram H; Azhar M; Jameel M; Bano K
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1515-22. PubMed ID: 25176246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Slim" nucleosides and nucleotides. I. Synthetic, structural and biophysical investigations of showdomycins.
    Mumper MW; Aurenge C; Hosmane RS
    J Biomol Struct Dyn; 1994 Apr; 11(5):1107-31. PubMed ID: 7524539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Showdomycin as a versatile chemical tool for the detection of pathogenesis-associated enzymes in bacteria.
    Böttcher T; Sieber SA
    J Am Chem Soc; 2010 May; 132(20):6964-72. PubMed ID: 20433172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Showdomycin analogues: synthesis and antitumor evaluation.
    Numao N; Hemmi H; Naujokaitis SA; Rabinovitz M; Beisler JA
    J Med Chem; 1981 May; 24(5):515-20. PubMed ID: 7241509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Pyrrole Intermediate Which Undergoes C-Glycosidation and Autoxidation to Yield the Final Product in Showdomycin Biosynthesis.
    Ren D; Kim M; Wang SA; Liu HW
    Angew Chem Int Ed Engl; 2021 Jul; 60(31):17148-17154. PubMed ID: 34048627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of nucleoside and nucleotide antibiotics prossessing five-membered base rings. A comparison of the glycosyl barrier for purine, pyrimidine and imidazole rings.
    Vijayaiakshmi KS; Yathindra N
    Biochim Biophys Acta; 1980 Mar; 607(1):171-80. PubMed ID: 7370262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical study of anthracycline antibiotic analogues--III. Conformational analysis on different 2, 6-dideoxy-2-halo-alpha-l-hexopyranoses by molecular mechanics and semiempirical methods.
    el Bergmi R; Molina Molina J
    Bioorg Med Chem; 1996 Feb; 4(2):151-63. PubMed ID: 8814875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the maleimide ring system on the structure-activity relationship of showdomycin.
    Rosenqvist P; Mäkinen JJ; Palmu K; Jokinen J; Prajapati RK; Korhonen HJ; Virta P; Belogurov GA; Metsä-Ketelä M
    Eur J Med Chem; 2022 Jul; 237():114342. PubMed ID: 35439612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis of trimeric maleimide substituted 1,5,9-triazacyclododecane HIV fusion scaffolds.
    Remmert S; Hollis H; Parish CA
    Bioorg Med Chem; 2009 Feb; 17(3):1251-8. PubMed ID: 19135378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-timescale molecular dynamics simulations of protein structure and function.
    Klepeis JL; Lindorff-Larsen K; Dror RO; Shaw DE
    Curr Opin Struct Biol; 2009 Apr; 19(2):120-7. PubMed ID: 19361980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulations.
    Zhang L; Hao GF; Tan Y; Xi Z; Huang MZ; Yang GF
    Bioorg Med Chem; 2009 Jul; 17(14):4935-42. PubMed ID: 19540767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revision of the structure assigned to the antibiotic BU-4664L from Micromonopora.
    Igarashi Y; Miyanaga S; Onaka H; Takeshita M; Furumai T
    J Antibiot (Tokyo); 2005 May; 58(5):350-2. PubMed ID: 16060388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation and intracellular phosphorylation of showdomycin.
    Arendes J; Zahn RK; Hantke E; Müller WE
    Cancer Lett; 1978 May; 4(5):259-64. PubMed ID: 657123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interaction of 4'-O-(a-l-Cladinosyl) daunorubicin with human serum albumin: The binding site II on HSA molecular using spectroscopy and modeling.
    Cui F; Kong X; Qin L; Zhang G; Liu Q; Lei B; Yao X
    J Photochem Photobiol B; 2009 Jun; 95(3):162-9. PubMed ID: 19345112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case.
    Papaleo E; Mereghetti P; Fantucci P; Grandori R; De Gioia L
    J Mol Graph Model; 2009; 27(8):889-99. PubMed ID: 19264523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of conformational stability and vibrational assignments of 1-aminocyclopropanecarboxylic acid c-C3H4(NH2)-COOH.
    Badawi HM
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):707-12. PubMed ID: 19398368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Showdomycin, a new nucleoside antibiotic.
    Roy-Burman S; Roy-Burman P; Visser DW
    Cancer Res; 1968 Aug; 28(8):1605-10. PubMed ID: 5691758
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
    Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
    Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.